List of Tables
Table 1. Global Human Hyperimmune Globulins Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human Hyperimmune Globulins Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human Hyperimmune Globulins Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Hyperimmune Globulins Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Human Hyperimmune Globulins Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Hyperimmune Globulins Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Hyperimmune Globulins Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Hyperimmune Globulins Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Hyperimmune Globulins, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Hyperimmune Globulins, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Hyperimmune Globulins, Product Type & Application
Table 12. Global Key Manufacturers of Human Hyperimmune Globulins, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Hyperimmune Globulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Hyperimmune Globulins as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Hyperimmune Globulins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Hyperimmune Globulins Sales by Region (2020-2025) & (K Units)
Table 18. Global Human Hyperimmune Globulins Sales Market Share by Region (2020-2025)
Table 19. Global Human Hyperimmune Globulins Sales by Region (2026-2031) & (K Units)
Table 20. Global Human Hyperimmune Globulins Sales Market Share by Region (2026-2031)
Table 21. Global Human Hyperimmune Globulins Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Hyperimmune Globulins Revenue Market Share by Region (2020-2025)
Table 23. Global Human Hyperimmune Globulins Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Hyperimmune Globulins Revenue Market Share by Region (2026-2031)
Table 25. North America Human Hyperimmune Globulins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Hyperimmune Globulins Sales by Country (2020-2025) & (K Units)
Table 27. North America Human Hyperimmune Globulins Sales by Country (2026-2031) & (K Units)
Table 28. North America Human Hyperimmune Globulins Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Hyperimmune Globulins Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Hyperimmune Globulins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Hyperimmune Globulins Sales by Country (2020-2025) & (K Units)
Table 32. Europe Human Hyperimmune Globulins Sales by Country (2026-2031) & (K Units)
Table 33. Europe Human Hyperimmune Globulins Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Hyperimmune Globulins Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Hyperimmune Globulins Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Hyperimmune Globulins Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Human Hyperimmune Globulins Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Human Hyperimmune Globulins Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Hyperimmune Globulins Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Hyperimmune Globulins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Hyperimmune Globulins Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Human Hyperimmune Globulins Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Human Hyperimmune Globulins Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Hyperimmune Globulins Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human Hyperimmune Globulins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human Hyperimmune Globulins Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Human Hyperimmune Globulins Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Human Hyperimmune Globulins Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human Hyperimmune Globulins Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Hyperimmune Globulins Sales (K Units) by Type (2020-2025)
Table 51. Global Human Hyperimmune Globulins Sales (K Units) by Type (2026-2031)
Table 52. Global Human Hyperimmune Globulins Sales Market Share by Type (2020-2025)
Table 53. Global Human Hyperimmune Globulins Sales Market Share by Type (2026-2031)
Table 54. Global Human Hyperimmune Globulins Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Hyperimmune Globulins Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Hyperimmune Globulins Revenue Market Share by Type (2020-2025)
Table 57. Global Human Hyperimmune Globulins Revenue Market Share by Type (2026-2031)
Table 58. Global Human Hyperimmune Globulins Price (US$/Unit) by Type (2020-2025)
Table 59. Global Human Hyperimmune Globulins Price (US$/Unit) by Type (2026-2031)
Table 60. Global Human Hyperimmune Globulins Sales (K Units) by Application (2020-2025)
Table 61. Global Human Hyperimmune Globulins Sales (K Units) by Application (2026-2031)
Table 62. Global Human Hyperimmune Globulins Sales Market Share by Application (2020-2025)
Table 63. Global Human Hyperimmune Globulins Sales Market Share by Application (2026-2031)
Table 64. Global Human Hyperimmune Globulins Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Hyperimmune Globulins Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Hyperimmune Globulins Revenue Market Share by Application (2020-2025)
Table 67. Global Human Hyperimmune Globulins Revenue Market Share by Application (2026-2031)
Table 68. Global Human Hyperimmune Globulins Price (US$/Unit) by Application (2020-2025)
Table 69. Global Human Hyperimmune Globulins Price (US$/Unit) by Application (2026-2031)
Table 70. CSL Behring Company Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. CSL Behring Human Hyperimmune Globulins Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Grifols Human Hyperimmune Globulins Product
Table 79. Grifols Recent Developments/Updates
Table 80. Biotest Company Information
Table 81. Biotest Description and Business Overview
Table 82. Biotest Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Biotest Human Hyperimmune Globulins Product
Table 84. Biotest Recent Developments/Updates
Table 85. Kedrion Company Information
Table 86. Kedrion Description and Business Overview
Table 87. Kedrion Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Kedrion Human Hyperimmune Globulins Product
Table 89. Kedrion Recent Developments/Updates
Table 90. Emergent Company Information
Table 91. Emergent Description and Business Overview
Table 92. Emergent Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Emergent Human Hyperimmune Globulins Product
Table 94. Emergent Recent Developments/Updates
Table 95. Kamada Company Information
Table 96. Kamada Description and Business Overview
Table 97. Kamada Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Kamada Human Hyperimmune Globulins Product
Table 99. Kamada Recent Developments/Updates
Table 100. CNBG Company Information
Table 101. CNBG Description and Business Overview
Table 102. CNBG Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. CNBG Human Hyperimmune Globulins Product
Table 104. CNBG Recent Developments/Updates
Table 105. Hualan Bio Company Information
Table 106. Hualan Bio Description and Business Overview
Table 107. Hualan Bio Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Hualan Bio Human Hyperimmune Globulins Product
Table 109. Hualan Bio Recent Developments/Updates
Table 110. Shanghai RAAS Company Information
Table 111. Shanghai RAAS Description and Business Overview
Table 112. Shanghai RAAS Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Shanghai RAAS Human Hyperimmune Globulins Product
Table 114. Shanghai RAAS Recent Developments/Updates
Table 115. CBPO Company Information
Table 116. CBPO Description and Business Overview
Table 117. CBPO Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. CBPO Human Hyperimmune Globulins Product
Table 119. CBPO Recent Developments/Updates
Table 120. Sichuan Yuanda Shuyang Company Information
Table 121. Sichuan Yuanda Shuyang Description and Business Overview
Table 122. Sichuan Yuanda Shuyang Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Sichuan Yuanda Shuyang Human Hyperimmune Globulins Product
Table 124. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 125. ADMA Biologics Company Information
Table 126. ADMA Biologics Description and Business Overview
Table 127. ADMA Biologics Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. ADMA Biologics Human Hyperimmune Globulins Product
Table 129. ADMA Biologics Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Human Hyperimmune Globulins Distributors List
Table 133. Human Hyperimmune Globulins Customers List
Table 134. Human Hyperimmune Globulins Market Trends
Table 135. Human Hyperimmune Globulins Market Drivers
Table 136. Human Hyperimmune Globulins Market Challenges
Table 137. Human Hyperimmune Globulins Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Hyperimmune Globulins
Figure 2. Global Human Hyperimmune Globulins Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Hyperimmune Globulins Market Share by Type: 2024 & 2031
Figure 4. Hepatitis B Immuneglobulins Product Picture
Figure 5. Rabies Immuneglobulins Product Picture
Figure 6. Tetanus Toxin Immuneglobulins Product Picture
Figure 7. Rho(D) Immune Globulin Product Picture
Figure 8. Cytomegalovirus Immune Globulin Product Picture
Figure 9. Varicella-Zoster Immune Globulin Product Picture
Figure 10. Others Product Picture
Figure 11. Global Human Hyperimmune Globulins Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global Human Hyperimmune Globulins Market Share by Application: 2024 & 2031
Figure 13. Government Institutions
Figure 14. Private Sector
Figure 15. Others
Figure 16. Global Human Hyperimmune Globulins Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Human Hyperimmune Globulins Market Size (2020-2031) & (US$ Million)
Figure 18. Global Human Hyperimmune Globulins Sales (2020-2031) & (K Units)
Figure 19. Global Human Hyperimmune Globulins Average Price (US$/Unit) & (2020-2031)
Figure 20. Human Hyperimmune Globulins Report Years Considered
Figure 21. Human Hyperimmune Globulins Sales Share by Manufacturers in 2024
Figure 22. Global Human Hyperimmune Globulins Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Human Hyperimmune Globulins Players: Market Share by Revenue in Human Hyperimmune Globulins in 2024
Figure 24. Human Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Human Hyperimmune Globulins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Human Hyperimmune Globulins Sales Market Share by Country (2020-2031)
Figure 27. North America Human Hyperimmune Globulins Revenue Market Share by Country (2020-2031)
Figure 28. United States Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Human Hyperimmune Globulins Sales Market Share by Country (2020-2031)
Figure 31. Europe Human Hyperimmune Globulins Revenue Market Share by Country (2020-2031)
Figure 32. Germany Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Human Hyperimmune Globulins Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Human Hyperimmune Globulins Revenue Market Share by Region (2020-2031)
Figure 39. China Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Human Hyperimmune Globulins Sales Market Share by Country (2020-2031)
Figure 49. Latin America Human Hyperimmune Globulins Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Human Hyperimmune Globulins Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Human Hyperimmune Globulins Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Human Hyperimmune Globulins Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Human Hyperimmune Globulins by Type (2020-2031)
Figure 59. Global Revenue Market Share of Human Hyperimmune Globulins by Type (2020-2031)
Figure 60. Global Human Hyperimmune Globulins Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Human Hyperimmune Globulins by Application (2020-2031)
Figure 62. Global Revenue Market Share of Human Hyperimmune Globulins by Application (2020-2031)
Figure 63. Global Human Hyperimmune Globulins Price (US$/Unit) by Application (2020-2031)
Figure 64. Human Hyperimmune Globulins Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
